Data Insights
                                    By  Company Name
                                
                                No Filter Selected
                                    By  Disease Name
                                
                                No Filter Selected
                                    By  Drug Name
                                
                                No Filter Selected
                                    By Themes
                                
                                No Filter Selected
                                    Showing 2 results out of 2                                
                                
                                                Data Insights
                                                
                                        AZD-5335 by AstraZeneca for Solid Tumor: Likelihood of Approval
AZD-5335 is under clinical development by AstraZeneca and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...
                                                Data Insights
                                                
                                        AZD-5335 by AstraZeneca for Ovarian Cancer: Likelihood of Approval
AZD-5335 is under clinical development by AstraZeneca and currently in Phase II for Ovarian Cancer. According to GlobalData, Phase II...